Skip to main content
Equibles
MCRB logo

MCRB · Seres Therapeutics, Inc. · Suppliers & Customers

Track MCRB — free

Use MCRB with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research MCRB.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$1.40 -0.01 (-0.71%) At close · Nov 13 Play latest call Q3 2025 earnings call transcript
Rebalance outlook locked
Going-concern doubt — flagged Nov 4, 2026

Substantial doubt about the company's ability to continue as a going concern.

“Therefore, there is substantial doubt about our ability to continue as a going concern for at least 12 months from the date that our condensed consolidated financial statements for the nine months ended September 30, 2026 were issued.”
View the 10-Q filed Nov 4, 2026
Market Cap
$14.27M
Shares
10.20M
Volume · Nov 13 59.95K Avg daily vol (3M) 73.12K

Supply Chain

Customers, suppliers, competitors and partners, private companies included: the ones MCRB names, and the companies that name MCRB.

Read supply chains in your AI or your code through MCP and the API →
Diagram Table Overlap
Pro

See who MCRB sells to, buys from, competes and partners with

  • 1 supplier
  • 1 customer
  • 1 competitor
  • 1 partner

Pro names each company, links it to its own page, shows any revenue share the filing states, and quotes the sentence it comes from.

View plans
Key facts CIK 1609809 CUSIP 81750R201 13F (30d) 42 filings 29 filers Visit website Investor relations